End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 USD | +4.50% | +4.50% | -6.51% |
30/05 | Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target | MT |
30/05 | Canaccord Genuity Starts Coverage on TriSalus Life Sciences With Buy Rating, $12 Price Target | MT |
- Stock Market
- Equities
- TLSI Stock
- News TriSalus Life Sciences, Inc.
- Press Releases